UnitedHealth Group (UNH) is a powerhouse in healthcare, offering steady growth and strong dividends. MarketBeat analyst Chris ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Morgan Stanley analyst Erin Wright maintained a Buy rating on UnitedHealth (UNH – Research Report) yesterday and set a price target of ...

Shares of UnitedHealth Group Inc. UNH shed 1.29% to $583.56 Monday, on what proved to be an all-around rough trading session ...

Analysts on Wall Street project that UnitedHealth Group (UNH) will announce quarterly earnings of $7.02 per share in its forthcoming report, representing an increase of 7% year over year. Revenues are ...

We estimate UnitedHealth Group’s Valuation to be $580 per share, close to its current levels of $600. Our forecast is based on a 21x P/E multiple for UNH and expected earnings of $27.55 on a per ...

Sept 10 (Reuters) - UnitedHealth Group (UNH.N), opens new tab said on Tuesday it will remove AbbVie’s (ABBV.N), opens new tab blockbuster rheumatoid arthritis drug Humira from some of its lists ...

Marquette Asset Management LLC decreased its position in UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 8.0% ...

Investors with a lot of money to spend have taken a bullish stance on UnitedHealth Group (NYSE:UNH). And retail traders should know. We noticed this today when the trades showed up on publicly ...

UnitedHealth Group and Centene are among health insurers expanding sales of individual coverage under the Affordable Care Act into scores of new counties for 2025. These expansions come amid the ...

On Tuesday, UnitedHealth Group Inc (UNH) stock saw a decline, ending the day at $581.58 which represents a decrease of $-1.98 or -0.34% from the prior close of $583.56. The stock opened at $588.06 and ...

The stock's fall snapped a two-day winning streak.